Nutromics’ drug monitoring patch secures FDA breakthrough designation

Breakthrough designation for Nutromics’ namesake patch applies to the wearable platform’s function in vancomycin drug monitoring. Breakthrough designation for Nutromics’ namesake patch applies to the wearable platform’s function in vancomycin drug monitoring. Nutromics’ wearable for vancomycin monitoring is its first product in development, with multi-analyte monitoring with its patch planned for development in future, among others. Credit: Tada Images/Shutterstock.com The US Food and Drug Administration (FDA) has granted breakthrough device designation to Nutromics’ microneedle wearable patch for vancomycin therapeutic drug monitoring. Approximately 2.9 million patients in the US receive vancomycin therapy every year, with the antibiotic used to treat life-threatening…

Source: Medical Device Network